HLI Form 144: Proposed Sale of 40,000 Shares (~$7.99M)
Houlihan Lokey (HLI) submitted a Form 144 notifying the proposed sale of 40,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,997,848.00 and an approximate sale date of 08/27/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Houlihan Lokey (HLI) submitted a Form 144 notifying the proposed sale of 40,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $7,997,848.00 and an approximate sale date of 08/27/2025. The shares were acquired as restricted stock vesting under a registered plan: 20,016 shares vested on 05/15/2023 and 19,984 shares vested on 05/15/2024, with payment described as services rendered. The filer reports no sales in the past three months and affirms no undisclosed material adverse information.
Positive
- None.
Negative
- Planned sale of 40,000 common shares representing an aggregate market value of $7,997,848.00 scheduled for 08/27/2025
- Insufficient filer identity/relationship details in the provided content, limiting ability to assess insider status or governance implications
Insights
TL;DR Officer/affiliate intends to sell 40,000 vested restricted shares valued near $8.0M; routine Rule 144 notice, limited immediate informational impact.
This Form 144 documents a planned Rule 144 sale of restricted shares that vested under a registered plan. The filing shows the shares were acquired via compensation (services rendered) in two vesting events in 2023 and 2024. The sale is routed through Morgan Stanley Smith Barney on the NYSE and is scheduled for 08/27/2025. The filing contains no disclosure of insider identity or additional context about motivation. For investors, the filing confirms an insider liquidity event but does not by itself indicate operational or financial deterioration.
TL;DR This is a compliance disclosure of a planned insider sale under Rule 144; governance implications are routine absent further details.
The Form 144 satisfies regulatory requirements by reporting the number of shares, acquisition dates, nature of acquisition (restricted stock vesting), broker details, and the approximate sale date. The statement that there were no securities sold in the past three months and the signer 27s attestation regarding material non-public information are standard. Because the filing omits the filer 27s name/relationship in the provided content, stakeholders cannot assess insider status or evaluate potential governance signaling beyond the sale itself.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filed for HLI disclose?
Did the filer report any HLI sales in the past three months?
Which broker and exchange are involved in the proposed HLI sale?
Does the Form 144 assert the filer possesses undisclosed material information?
AI-generated analysis. How Rhea-AI works. Not financial advice.